<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01618071</url>
  </required_header>
  <id_info>
    <org_study_id>DRINC 11-LO-0116</org_study_id>
    <secondary_id>BB/1005862/1</secondary_id>
    <nct_id>NCT01618071</nct_id>
  </id_info>
  <brief_title>Vascular Effects of Triglyceride-rich Lipoproteins</brief_title>
  <official_title>Unravelling the Mechanisms of Vascular Protection by n3-PUFAs to Optimise and Support Their Use as Bioactives by the Food Industry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Veterinary College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many types of cardiovascular disease begin when the layer of cells lining blood vessels
      (endothelial cells) start to function abnormally. This causes white blood cells (monocytes)
      to enter the blood vessel wall and eventually form lesions. Fats from foods we consume are
      carried in the blood for 3-8 hours after a fatty meal in small particles known as
      chylomicrons (CM) and chylomicron remnants (CMR). The overall aim of this project is to
      investigate the idea that n-3 polyunsaturated fatty acids (PUFA) protect against heart
      disease by modifying the effect of CMR on endothelial cells and monocytes. We hypothesize
      that n3-PUFA carried in CMR reduce detrimental events which promote blood vessel damage and
      activate protective mechanisms to improve the function of arteries.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Activation of inflammatory/oxidative stress pathways within cultured endothelial cells following treatment with 6 h postprandial chylomicron remnant-rich lipoprotein fraction</measure>
    <time_frame>6 h post-meal</time_frame>
    <description>The primary outcome of the study is activation of inflammatory/oxidative stress pathways within cultured endothelial cells following incubation with pooled postprandial lipoprotein fractions rich in chylomicron remnants. Due to the nature of this type of research this necessitates more than one primary outcome measure: the primary measures are NF-kappa-beta activation, cytokine production (e.g. interleukin-6) and reactive oxygen species generation in the cultured human endothelial cells.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the plasma concentration versus time curve (iAUC) of triacylglycerol</measure>
    <time_frame>0, 1, 2, 3, 4, 5 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the plasma concentration versus time curve (iAUC) of glucose</measure>
    <time_frame>0, 1, 2, 3, 4, 5 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the plasma concentration versus time curve (iAUC) for non-esterified fatty acids</measure>
    <time_frame>0, 1, 2, 3, 4, 5 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the plasma concentration versus time curve (iAUC) for plasma fatty acid composition (%)</measure>
    <time_frame>0, 1, 2, 3, 4, 5 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the plasma concentration versus time curve (iAUC) for cholesterol</measure>
    <time_frame>0, 1, 2, 3, 4, 5 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the unit measure versus time curve for brachial augmentation index</measure>
    <time_frame>0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the unit measure versus time curve for systolic blood pressure</measure>
    <time_frame>0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the unit measure versus time curve for diastolic blood pressure</measure>
    <time_frame>0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in digital volume pulse stiffness index</measure>
    <time_frame>0, 2, 4 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in digital volume pulse reflection index</measure>
    <time_frame>0, 2, 4 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma nitrite/nitrate concentrations</measure>
    <time_frame>0, 2, 4 and 6 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma 8-isoprostane F2alpha concentrations</measure>
    <time_frame>0, 2, 4 and 6 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activation of inflammatory/oxidative stress pathways within cultured endothelial cells following treatment with 4 h postprandial chylomicron remnant-rich lipoprotein fraction</measure>
    <time_frame>4 h post-meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activation of inflammatory/oxidative stress pathways within cultured endothelial cells following treatment with 5 h postprandial chylomicron remnant-rich lipoprotein fraction</measure>
    <time_frame>5 h post-meal</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Postprandial Period</condition>
  <condition>Lipemia</condition>
  <condition>Vasodilation</condition>
  <condition>Vascular Resistance</condition>
  <condition>Nitric Oxide</condition>
  <arm_group>
    <arm_group_label>Oleic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75 g high oleic acid sunflower oil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Linoleic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75 g high linoleic acid sunflower oil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eicosapentaenoic acid and docosahexaenoic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 g EPA and DHA derived from fish oil, made up to a total of 75 g with high oleic sunflower oil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Docosahexaenoic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 g DHA derived from algal oil, made up to a total of 75 g with high oleic sunflower oil.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High-fat meals varying in their fatty acid composition</intervention_name>
    <description>70 g fat incorporated into a muffin and milkshake meal, consumed following fasting baseline measurements</description>
    <arm_group_label>Oleic acid</arm_group_label>
    <arm_group_label>Linoleic acid</arm_group_label>
    <arm_group_label>Eicosapentaenoic acid and docosahexaenoic acid</arm_group_label>
    <arm_group_label>Docosahexaenoic acid</arm_group_label>
    <other_name>DHASCO</other_name>
    <other_name>Purified fish oil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males

          -  Non-smokers

          -  Aged 35-70 years

          -  Fasting TAG concentrations ≥1.2 mmol/L.

        Exclusion Criteria:

          -  Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke),
             impaired fasting glucose/uncontrolled type 2 diabetes (or fasting glucose ≥ 6.1
             mmol/L), cancer, kidney, liver or bowel disease.

          -  Presence of gastrointestinal disorder or use of drug, which is likely to alter
             gastrointestinal motility or nutrient absorption.

          -  History of substance abuse or alcoholism (previous weekly alcohol intake &gt;60
             units/men)

          -  Current self-reported weekly alcohol intake exceeding 28 units

          -  Allergy or intolerance to any component of test meals

          -  Unwilling to restrict consumption of any source of fish oil for the length of the
             study

          -  Weight change of &gt;3kg in preceding 2 months

          -  Body Mass Index &lt;20 and &gt;35 kg/m2

          -  Fasting blood cholesterol &gt; 7.8 mmol/L

          -  Current cigarette smoker.

          -  Current use of lipid lowering medication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy L Hall, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King's College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetes &amp; Nutritional Sciences Division, King's College London</name>
      <address>
        <city>London</city>
        <zip>SE1 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Lambert MS, Botham KM, Mayes PA. Modification of the fatty acid composition of dietary oils and fats on incorporation into chylomicrons and chylomicron remnants. Br J Nutr. 1996 Sep;76(3):435-45.</citation>
    <PMID>8881715</PMID>
  </reference>
  <reference>
    <citation>Botham KM, Bravo E, Elliott J, Wheeler-Jones CP. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development. Curr Pharm Des. 2005;11(28):3681-95. Review.</citation>
    <PMID>16305504</PMID>
  </reference>
  <reference>
    <citation>Proctor SD, Vine DF, Mamo JC. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002 Oct;13(5):461-70. Review.</citation>
    <PMID>12352009</PMID>
  </reference>
  <reference>
    <citation>Marcoux C, Hopkins PN, Wang T, Leary ET, Nakajima K, Davignon J, Cohn JS. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res. 2000 Sep;41(9):1428-36.</citation>
    <PMID>10974050</PMID>
  </reference>
  <reference>
    <citation>Hall WL, Sanders KA, Sanders TA, Chowienczyk PJ. A high-fat meal enriched with eicosapentaenoic acid reduces postprandial arterial stiffness measured by digital volume pulse analysis in healthy men. J Nutr. 2008 Feb;138(2):287-91.</citation>
    <PMID>18203893</PMID>
  </reference>
  <reference>
    <citation>Burdge GC, Powell J, Dadd T, Talbot D, Civil J, Calder PC. Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50-65 years. Br J Nutr. 2009 Jul;102(1):160-5. doi: 10.1017/S0007114508143550. Epub 2009 Jan 13.</citation>
    <PMID>19138437</PMID>
  </reference>
  <reference>
    <citation>Zampelas A, Peel AS, Gould BJ, Wright J, Williams CM. Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men. Eur J Clin Nutr. 1994 Dec;48(12):842-8.</citation>
    <PMID>7889892</PMID>
  </reference>
  <reference>
    <citation>Armah CK, Jackson KG, Doman I, James L, Cheghani F, Minihane AM. Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clin Sci (Lond). 2008 Jun;114(11):679-86.</citation>
    <PMID>18052925</PMID>
  </reference>
  <reference>
    <citation>Rontoyanni VG, Hall WL, Pombo-Rodrigues S, Appleton A, Chung R, Sanders TA. A comparison of the changes in cardiac output and systemic vascular resistance during exercise following high-fat meals containing DHA or EPA. Br J Nutr. 2012 Aug;108(3):492-9. doi: 10.1017/S0007114511005721. Epub 2012 Feb 21.</citation>
    <PMID>22348439</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2012</study_first_submitted>
  <study_first_submitted_qc>June 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2012</study_first_posted>
  <last_update_submitted>October 10, 2012</last_update_submitted>
  <last_update_submitted_qc>October 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King's College London</investigator_affiliation>
    <investigator_full_name>Dr Wendy Hall</investigator_full_name>
    <investigator_title>Lecturer in Nutritional Sciences</investigator_title>
  </responsible_party>
  <keyword>n-3 PUFA</keyword>
  <keyword>Endothelial cells</keyword>
  <keyword>Nitric oxide</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Vasodilation</keyword>
  <keyword>Lipemia</keyword>
  <keyword>Unsaturated dietary fats</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

